PLA2G7 and COVID-19: Since this marker is more associated with atherosclerosis [31], and there was no difference in the presence of coronary artery disease between our two COVID-19 cohorts (Table 1), this is why we think that severe SARS-CoV-2 infection could not induce Lp-PLA2 activity in these patients.